Results 1 to 10 of about 45,547 (280)

Myositis

open access: yesZeitschrift für Rheumatologie, 2022
ZusammenfassungUnter der Federführung der Deutschen Gesellschaft für Neurologie und Beteiligung vieler weiterer Fachgesellschaften wurde die S2k-Leitlinie zu Myositissyndromen vollständig aktualisiert und überarbeitet. Bei der Klassifikation der Myositiden werden nun die immunmediierte nekrotisierende Myopathie und das Antisynthetasesyndrom als ...
Peter Korsten, Eugen Feist
openaire   +4 more sources

Rheumatoid Myositis: A Rare Case Report [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2023
Rheumatoid Arthritis (RA) and inflammatory myositis are distinct clinical syndromes. Muscle involvement in RA is frequently secondary to therapy with steroids or immune-modulators medication.
Satish Kumar   +2 more
doaj   +2 more sources

Prevalence and Risk of Falls and Fractures in the Idiopathic Inflammatory Myopathies: A Cross-Sectional Study of 470 Patients. [PDF]

open access: yesRheumatol Ther
Introduction Patients with idiopathic inflammatory myopathies (IIMs) can develop marked muscle weakness, which predisposes them to falls and injuries. We examined the prevalence of falls and associated fractures, assistive device use, and bone-protective
Nandakumar D   +5 more
europepmc   +2 more sources

Cancer in myositis

open access: yesIndian Journal of Rheumatology, 2020
There is an intriguing relationship between cancer and myositis. The immunosuppressive agents commonly used to treat myositis patients are known to favor the development of cancer, but this factor does not seem to be the main cause of the association ...
Albert Selva-O'Callaghan   +3 more
doaj   +2 more sources

Focal Myositis Localised in Gastrocnemius Muscle: is it Different from Isolated Gastrocnemius Myositis? A Case Report [PDF]

open access: yesMalaysian Orthopaedic Journal, 2021
Focal myositis is a rare disease defined by an isolated inflammatory pseudotumour usually restricted to one skeletal muscle. Approximately, 250 cases of focal myositis have been described in the literature, and two recent large cohorts have been used to ...
Son IS, Kim JS, Yoo SJ, Kang MS, Hyun CL
doaj   +1 more source

miR-18a-3p and Its Target Protein HuR May Regulate Myogenic Differentiation in Immune-Mediated Necrotizing Myopathy

open access: yesFrontiers in Immunology, 2022
Immune-mediated necrotizing myopathy (IMNM) is characterized by manifestation of myonecrosis and regeneration of muscle fibers; however, the underlying pathogenesis remains unclear. This study aimed to investigate the role and mechanism of miR-18a-3p and
Lifang Ye   +8 more
doaj   +1 more source

Different Multivariable Risk Factors for Rapid Progressive Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis and Anti-Synthetase Syndrome

open access: yesFrontiers in Immunology, 2022
BackgroundInterstitial lung disease (ILD) is frequently observed in anti-melanoma differentiation-associated protein 5 (MDA5) antibody positive dermatomyositis (DM) and anti-synthetase syndrome (ASS), where they often develop a rapidly progressive ILD ...
Yu Zuo   +8 more
doaj   +1 more source

Adrenomedullin Expression Is Associated With the Severity and Poor Prognosis of Interstitial Lung Disease in Dermatomyositis Patients

open access: yesFrontiers in Immunology, 2022
ObjectiveTo evaluate adrenomedullin mRNA levels in the peripheral blood mononuclear cells (PBMCs) of patients with dermatomyositis (DM) as well as their correlation with the severity of interstitial lung disease (ILD).MethodsA total of 41 DM patients and
Lifang Ye   +13 more
doaj   +1 more source

Resistin Expression Is Associated With Interstitial Lung Disease in Dermatomyositis

open access: yesFrontiers in Medicine, 2022
ObjectiveIn the current study, we aimed to assess resistin mRNA levels in the peripheral blood mononuclear cells (PBMCs) of dermatomyositis patients with interstitial lung disease (DM-ILD) and their correlation with disease activity.MethodsWe detected ...
Lifang Ye   +15 more
doaj   +1 more source

Interstitial lung disease is not rare in immune-mediated necrotizing myopathy with anti-signal recognition particle antibodies

open access: yesBMC Pulmonary Medicine, 2022
Objectives The purpose was to clarify the characteristics of interstitial lung disease (ILD) in immune-mediated necrotizing myopathy (IMNM) patients with anti-signal recognition particle (SRP) antibodies.
Yongpeng Ge   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy